Both in Biotechnology
ImmunityBio vs Krystal Biotech
Over the past year IBRX returned +283.7% and KRYS returned +88.4%; their daily moves had a correlation of 0.14.
IBRX +283.7% KRYS +88.4%Growth of $1, one year, split-adjusted
| Metric | IBRX | KRYS |
|---|---|---|
| Price | $9.44 | $332.56 |
| Market cap | $10.00B | $9.84B |
| Today | +6.91% | −0.75% |
| 1 month | +18.7% | −7.5% |
| 6 months | +23.1% | +28.7% |
| Year to date | +376.8% | +34.9% |
| 1 year | +267.3% | +88.2% |
| Revenue growth (YoY) | +93.9% | +24.1% |
| Gross margin | 99.4% | 94.6% |
| Net margin | −449.6% | 45.9% |
| P/E (TTM) | — | 40.8× |
| Price / sales | 60.3× | 22.3× |
| Net cash | -$57.7M | $845.6M |
| Dividend yield | — | — |
| Volatility (60d) | 61.9% | 42.5% |
| Short % of float | 31.7% | 13.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).